admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

MYND Life Sciences Provides Corporate Update

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

PT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create...

Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical...

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental...

COMPASS Pathways joins forces with King’s College London and South London...

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill...

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional...

1...203204205...218 Page 204 of 218

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin